IAG933

N/A

Report date: 2023/04/23 17:24:37
NME

Base Information

Drug NameIAG933
Drug Alias NameIAG-933IAG933
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionYAP and TEAD interaction inhibitor
TargetsTranscriptional coactivator YAP1Transcriptional enhancer factor
Therapy Area/IndicationsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[11] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A